SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-065951
Filing Date
2015-11-16
Accepted
2015-11-16 15:56:38
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v423780_10q.htm 10-Q 704917
2 EXHIBIT 31 v423780_ex31.htm EX-31 8757
3 EXHIBIT 32 v423780_ex32.htm EX-32 5457
  Complete submission text file 0001144204-15-065951.txt   6472002

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT vgen-20150930.xml EX-101.INS 1598933
5 XBRL TAXONOMY EXTENSION SCHEMA vgen-20150930.xsd EX-101.SCH 53628
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vgen-20150930_cal.xml EX-101.CAL 43178
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vgen-20150930_def.xml EX-101.DEF 369407
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vgen-20150930_lab.xml EX-101.LAB 400460
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vgen-20150930_pre.xml EX-101.PRE 428202
Mailing Address 949 FELL STREET BALTIMORE MD 21231
Business Address 949 FELL STREET BALTIMORE MD 21231 410-387-4000
VACCINOGEN INC (Filer) CIK: 0001453001 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 10-Q | Act: 34 | File No.: 000-54997 | Film No.: 151234141
SIC: 2834 Pharmaceutical Preparations